Clinical studies on the reversal of the neuromuscular blockade produced by pancuronium bromide. I. The effects of glycopyrrolate and pyridostigmine.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001285:Atropine / Q000494:pharmacology; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004491:Edrophonium / Q000494:pharmacology; D005260:Female; D006024:Glycopyrrolate / Q000494:pharmacology*; D006801:Humans; D006919:Hydroxyzine / Q000494:pharmacology; D008297:Male; D008614:Meperidine / Q000494:pharmacology; D008875:Middle Aged; D009469:Neuromuscular Junction / Q000187:drug effects*; D010197:Pancuronium / Q000037:antagonists & inhibitors*; D011729:Pyridostigmine Bromide / Q000494:pharmacology*; D011759:Pyrrolidines / Q000494:pharmacology*
D004338:Drug Combinations; D011759:Pyrrolidines; D006919:Hydroxyzine; D004491:Edrophonium; D001285:Atropine; D008614:Meperidine; D010197:Pancuronium; D011729:Pyridostigmine Bromide; D006024:Glycopyrrolate